Ranolazine
Important Notice: For research use only. We do not sell to patients.
Other Forms of Ranolazine
Not your Region? View all Distributors
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Discription | Ranolazine is a partial fatty acid oxidation inhibitor, shifts ATP production from fatty acid to more oxygen-efficient carbohydrate oxidation. | ||
---|---|---|---|
Targets |
|
Catalog Num | A10780 |
---|---|
Formula | C24H33N3O4 |
Molecular Weight | 427.5 |
CAS Number | 95635-55-5 |
SMILES | CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O |
Synonyms | Ranexa |
Storage | Store lyophilized at -20ºC, keep desiccated. |
In vitro | DMSO | 77 mg/mL (180.1 mM) | |
Water | Insoluble | ||
Ethanol | 18 mg/mL (42.09 mM) | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 23.39 mL | 116.96 mL | 233.92 mL |
0.5 mM | 4.68 mL | 23.39 mL | 46.78 mL |
1 mM | 2.34 mL | 11.7 mL | 23.39 mL |
5 mM | 0.47 mL | 2.34 mL | 4.68 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2